The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Open accessAbstract
Fungal bloodstream infections are associated with significant patient mortality and health care costs. Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established. A retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted. One hundred fifty-seven patients with a Candida bloodstream infection were identified over a 4-year period (January 2001 through December 2004). Fifty (31.8%) patients died during hospitalization. One hundred thirty-four patients had empiric antifungal treatment begun after the results of fungal cultures were known. From the time that the first blood sample for culture that was positive was drawn, 9 (5.7%) patients received antifungal treatment within 12 h, 10 (6.4%) patients received antifungal treatment between 12 and 24 h, 86 (54.8%) patients received antifungal treatment between 24 and 48 h, and 52 (33.1%) patients received antifungal treatment after 48 h. Multiple logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio [AOR], 1.24; 95% confidence interval [CI], 1.18 to 1.31; P < 0.001), prior antibiotic treatment (AOR, 4.05; 95% CI, 2.14 to 7.65; P = 0.028), and administration of antifungal treatment 12 h after having the first positive blood sample for culture (AOR, 2.09; 95% CI, 1.53 to 2.84; P = 0.018) as independent determinants of hospital mortality. Administration of empiric antifungal treatment 12 h after a positive blood sample for culture is drawn is common among patients with Candida bloodstream infections and is associated with greater hospital mortality. Delayed treatment of Candida bloodstream infections could be minimized by the development of more rapid diagnostic techniques for the identification of Candida bloodstream infections. Alternatively, increased use of empiric antifungal treatment in selected patients at high risk for fungal bloodstream infection could also reduce delays in treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Finally, in a study of 10,811 patients treated in four Utah hospitals, each hour delay in time from ED arrival to administration of antimicrobials was associated with 1.16 increased odds of in-hospital and 1.10 increased odds of 1-year mortality (1.13 in patients with hypotension vs 1.09 in patients without hypotension) (111).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredIn the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [173]
In the citing paper
“As mentioned previously, diagnosis of invasive candidiasis and candidemia remains a great challenge, since symptoms and signs are usually non-specific, microbiological cultures are difficult to analyze, and histological specimens require invasive procedures [29,30,46].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [30]
In the citing paper
“Another single-center retrospective cohort of 157 consecutive patients with a Candida BSI showed a trend toward improved survival when appropriate antifungal therapy was administered within 12 hours of blood culture collection (mortality 11.1% vs 33.1%; P 5 .169).45”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“In multivariate analysis the odds of death was 2-fold higher if adequate therapy was delayed more than 12 hours (P 5 .018).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high mortality rates due to delays in recognition and initiation of appropriate antifungals.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“There is extensive clinical evidence that delayed initiation of appropriate antifungal treatment is associated with increased mortality in patients with invasive candidiasis [70,71,72].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“Mortality rates are estimated to be as high as 45% [16], probably due to inefficient diagnostic methods and inappropriate initial antifungal therapies [17].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [17]
In the citing paper
“The Clinical and Laboratory Standards Institute (CLSI) Subcommittee for Antifungal Testing has developed standardized broth microdilution (BMD) (169) and disk diffusion (170) methods for in vitro susceptibility testing of Candida spp.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Reller, L. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,225
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,119
Cited by
Sorted by citations
Items 101–200 of 1,000
Klingspor, L., Tortorano, A. M., Peman, J., Willinger, B., Hamal, P., Sendid, B., Velegraki, A., Kibbler, C., Meis, J. F., Sabino, R., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.08.011 · Cited by 137
Ruhnke, M., Rickerts, V., Cornely, O. A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02040.x · Cited by 140
Systemic antifungal therapy in critically ill patients without invasive fungal infection*
Azoulay, É., Dupont, H., Tabah, A., Lortholary, O., Stahl, J. ‐., Français, A., Martin, C., Guidet, B., & Timsit, J. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236f297 · Cited by 136
Antifungal serum concentration monitoring: an update
Goodwin, M. L., & Drew, R. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm389 · Cited by 136
Das, I., Nightingale, P., Patel, M., & Jumaa, P. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.06.006 · Cited by 136
Stevenson, M., Pandor, A., James, M. M., Rafia, R., Uttley, L., Stevens, J., Sanderson, J., Wong, R., Perkins, G. D., McMullan, R., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20460 · Cited by 141
Pfaller, M. A., Diekema, D. J., Procop, G. W., & Rinaldi, M. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00403-07 · Cited by 135
(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Jaijakul, S., Vázquez, J. A., Swanson, R. N., & Ostrosky-Zeichner, L. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis456 · Cited by 137
Diagnosis of invasive candidiasis in the ICU
Eggimann, P., Billé, J., & Marchetti, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-37 · Cited by 138
Effect of antifungal therapy timing on mortality in cancer patients with candidemia
Taur, Y., Cohen, N., Dubnow, S., Paskovaty, A., & Seo, S. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00945-09 · Cited by 127
Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.03.002 · Cited by 130
Ghosh, A. K., Paul, S., Sood, P., Rudramurthy, S. M., Rajbanshi, A., Jillwin, T. J., & Chakrabarti, A. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.11.009 · Cited by 128
Pfaller, M. A., Messer, S. A., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. S., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00946-09 · Cited by 128
A review of Candida species causing blood stream infection
Giri, S., & Kindo, A. J. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99484 · Cited by 132
Zilberberg, M. D., Kollef, M. H., Arnold, H., Labelle, A., Micek, S. T., Kothari, S., & Shorr, A. F. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-150 · Cited by 128
Self-citationThe case for antifungal stewardship
Ananda-Rajah, M. R., Slavin, M. A., & Thursky, K. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e0680 · Cited by 128
Kayaaslan, B., Eser, F., Kaya Kalem, A., Bilgic, Z., Asilturk, D., Hasanoglu, I., Ayhan, M., Tezer Tekce, Y., Erdem, D., Turan, S., et al. (2021) · Mycoses · doi:10.1111/myc.13332 · Cited by 126
Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125
Antifungal stewardship considerations for adults and pediatrics
Hamdy, R. F., Zaoutis, T. E., & Seo, S. K. (2016) · Virulence · doi:10.1080/21505594.2016.1226721 · Cited by 124
Obeng, A. O., Egelund, E. F., Alsultan, A., Peloquin, C. A., & Johnson, J. A. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1400 · Cited by 124
Adapting to survive: How Candida overcomes host-imposed constraints during human colonization
Alves, R. M. A., Barata-Antunes, C., Casal, M., Brown, A. J. P., Dijck, P. V., & Paiva, S. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008478 · Cited by 126
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Grim, S. A., Berger, K., Teng, C. B., Gupta, S., Layden, J. E., Janda, W. M., & Clark, N. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr511 · Cited by 119
Lau, A. F., Halliday, C. L., Chen, S. C.-A., Playford, E. G., Stanley, K. K., & Sorrell, T. C. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01650-09 · Cited by 119
Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase
Kahn, J. N., Garcia-Effron, G., Hsu, M.-J., Park, S., Marr, K. A., & Perlin, D. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00067-07 · Cited by 118
Guery, B. P., Arendrup, M. C., Auzinger, G. M., Azoulay, É., Borges-Sa, M., Johnson, E. M., Müller, E. E., Putensen, C., Rotstein, C., Sganga, G., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1339-6 · Cited by 116
Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
Piper, L., Smith, P. B., Hornik, C. P. V., Cheifetz, I. M., Barrett, J. S., Moorthy, G., Hope, W. W., Wade, K. C., Cohen‐Wolkowiez, M., & Benjamin, D. K. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318202cbb3 · Cited by 118
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 123
Inhibition of Filamentation Can Be Used To Treat Disseminated Candidiasis
Saville, S. P., Lazzell, A. L., Bryant, A. P., Fretzen, A., Monreal, A., Solberg, E. O., Monteagudo, C. C., Lopez-Ribot, J. L., & Milne, G. T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00628-06 · Cited by 115
Garnacho‐Montero, J., Díaz‐Martín, A., García-Cabrera, E., de Pipaón, M. R. P., Hernandez-Caballero, C., & Lepe, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks347 · Cited by 113
Lin, M. Y., Weinstein, R. A., & Hota, B. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01553-07 · Cited by 112
Treatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis*
Thiel, S. W., Asghar, M. F., Micek, S. T., Reichley, R. M., Doherty, J. A., & Kollef, M. H. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e318196206b · Cited by 111
Self-citationGherardi, G., Angeletti, S., Panitti, M., Pompilio, A., Bonaventura, G. D., Crea, F., Avola, A., Fico, L., Palazzo, C., Sapia, G. F., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.09.015 · Cited by 108
Deresinski, S. C. (2007) · Clinical Infectious Diseases · doi:10.1086/519472 · Cited by 111
Time to positive culture and identification for Candida blood stream infections
Fernandez, J., Erstad, B. L., Petty, W., & Nix, D. E. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.04.002 · Cited by 106
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
Leroy, O., Bailly, S., Gangneux, J.-P., Mira, J.-P., Devos, P., Dupont, H., Montravers, P., Perrigault, P.-F., Constantin, J.-M., Guillemot, D., et al. (2016) · Annals of Intensive Care · doi:10.1186/s13613-015-0103-7 · Cited by 102
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study
Bassetti, M., Merelli, M., Ansaldi, F., de Florentiis, D., Sartor, A., Scarparo, C., Callegari, A., & Righi, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127534 · Cited by 109
Candida Infections in Solid Organ Transplantation
Silveira, F. P., & Kusne, S. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12114 · Cited by 105
Bloodstream infections in the Intensive Care Unit
Bassetti, M., Righi, E., & Carnelutti, A. (2016) · Virulence · doi:10.1080/21505594.2015.1134072 · Cited by 112
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
Prescott, H. C., Antonelli, M. M., Alhazzani, W. A., Møller, M. H., Alshamsi, F. E., Azevedo, L. C. P., Belley‐Côté, E. P., Waele, J. D., Derde, L. P. G., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 149
Oxman, D., Chow, J. K. L., Frendl, G., Hadley, S., Hershkovitz, S., Ireland, P., McDermott, L. A., Tsai, K., Marty, F. M., Kontoyiannis, D. P., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq136 · Cited by 104
Antifungals: From Pharmacokinetics to Clinical Practice
do Carmo, A., Rocha, M. J., Pereirinha, P., Tomé, R., & Costa, E. (2023) · Antibiotics · doi:10.3390/antibiotics12050884 · Cited by 115
Chi, H.-W., Yang, Y.-S., Shang, S.-T., Chen, K.-H., Yeh, K.-M., Chang, F.-Y., & Lin, J.-C. (2011) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2010.08.010 · Cited by 103
Candida in Solid Organ Transplant Recipients
Pappas, P. G., & Silveira, F. P. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02909.x · Cited by 104
Held, J., Kohlberger, I., Rappold, E., Grawitz, A. B., & Häcker, G. A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02473-12 · Cited by 102
Mellinghoff, S. C., Hoenigl, M., Koehler, P. A., Kumar, A., Lagrou, K., Lass‐Flörl, C., Meis, J. F. G. M., Menon, V. P., Rautemaa‐Richardson, R., & Cornely, O. A. (2018) · Mycoses · doi:10.1111/myc.12746 · Cited by 105
Shorr, A. F., Lazarus, D. R., Sherner, J. H., Jackson, W. L., Morrel, M., Fraser, V. J., & Kollef, M. H. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259379.97694.00 · Cited by 100
Self-citationTreatment of invasive candidiasis in the elderly: a review
Dimοpoulos, G., Flevari, A., Θεοδωρακοπούλου, Μ., VELEGRAKI, & Armaganidis (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s39120 · Cited by 107
The Candidemia Study Group, Barchiesi, F., Orsetti, E., Gesuita, R., Skrami, E., & Manso, E. (2015) · Infection · doi:10.1007/s15010-015-0845-z · Cited by 100
Knitsch, W., Vincent, J., Utzolino, S., François, B., Dinya, T., Dimοpoulos, G., Özgüneş, İ., Valía, J. C., Eggimann, P., León, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ707 · Cited by 101
The current treatment landscape: Candidiasis
Bassetti, M., Peghin, M., & Timsit, J.-F. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw392 · Cited by 99
Antifungal therapy in invasive fungal infections
Chen, S. C. ‐., Playford, E. G., & Sorrell, T. C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.002 · Cited by 98
Antimicrobial Stewardship in the Intensive Care Unit
Lawrence, K., & Kollef, M. H. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1394cp · Cited by 98
Self-citationWheat, L. J. (2006) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00165.x · Cited by 99
Kumar, A. (2007) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(08)70305-8 · Cited by 98
Early treatment of candidemia in adults: a review
Ostrosky-Zeichner, L., Kullberg, B. J., Bow, E. J., Hadley, S., León, C., Nucci, M., Patterson, T. F., & Perfect, J. R. (2011) · Medical Mycology · doi:10.3109/13693786.2010.512300 · Cited by 97
Utility of Ophthalmologic Screening for Patients With Candida Bloodstream Infections
Breazzano, M. P., Day, H. R., Bloch, K. C., Tanaka, S., Cherney, E. F., Sternberg, P. W., Donahue, S. P., & Bond, J. B. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.0733 · Cited by 98
Host response toCandida albicansbloodstream infection and sepsis
Duggan, S., Leonhardt, I., Hünniger, K., & Kurzai, O. (2015) · Virulence · doi:10.4161/21505594.2014.988096 · Cited by 107
Nine Things Genomics Can Tell Us About Candida auris
Chybowska, A. D., Childers, D. S., & Farrer, R. A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00351 · Cited by 102
Trends in invasive fungal infections, with emphasis on invasive aspergillosis
Erjavec, Z., Kluin‐Nelemans, H. C., & Verweij, P. E. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02929.x · Cited by 94
The Japanese guidelines for the management of sepsis
Oda, S., Aibiki, M., Ikeda, T., Imaizumi, H., Endo, S., Ochiai, R., Kotani, J., Shime, N., Nishida, O., Noguchi, T., et al. (2014) · Journal of Intensive Care · doi:10.1186/s40560-014-0055-2 · Cited by 94
Gaitán, A. C. R., Martínez, H., Moret, A. M., Calabuig, E., Tasias, M., Alastruey‐Izquierdo, A., Zaragoza, Ó., Mollar, J., Frasquet, J., Salavert, M., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1592675 · Cited by 93
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia
Arnold, H. M., Micek, S. T., Shorr, A. F., Zilberberg, M. D., Labelle, A. J., Kothari, S., & Kollef, M. H. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.4.361 · Cited by 94
Self-citationThe effect of time to antifungal therapy on mortality in candidemia associated septic shock
Patel, G. P., Simon, D., Scheetz, M., Crank, C. W., Lodise, T., & Patel, N. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181a1afb7 · Cited by 92
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott, D. J., Playford, E. G., Chen, S., Slavin, M., Nguyen, Q., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2009) · Critical Care · doi:10.1186/cc7964 · Cited by 93
Blot, S. I., Vandewoude, K. H., & Waele, J. J. D. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328028fd92 · Cited by 93
Leroy, G., Lambiotte, F., Thévenin, D., Lemaire, C., Parmentier, E., Devos, P., & Leroy, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-50 · Cited by 92
Invasive candidiasis in intensive care units in China: a multicentre prospective observational study
Guo, F., Yang, Y., Kang, Y., Zang, B., Cui, W., Qin, B., Qin, Y., Fang, Q., Qin, T., Jiang, D., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt083 · Cited by 91
Recent advances in delivery of antifungal agents for therapeutic management of candidiasis
Sawant, B., & Khan, T. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.127 · Cited by 94
Non–Culture-Based Diagnostics for Opportunistic Fungi
Mennink‐Kersten, M. A. S. H., & Verweij, P. E. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.009 · Cited by 92
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Cortegiani, A., Russotto, V., Maggiore, A., Attanasio, M., Naro, A. R., Raineri, S. M., & Giarratano, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920.pub3 · Cited by 91
Turecka, K., Chylewska, A., Kawiak, A., & Waleron, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01594 · Cited by 94
Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies
Polvi, E. J., Li, X., O’Meara, T. R., Leach, M. D., & Cowen, L. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1860-z · Cited by 94
Antifungal drug resistance: do molecular methods provide a way forward?
Perlin, D. S. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283321ce5 · Cited by 89
Treatment options of invasive fungal infections in adults
Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 90
Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
Lewis, R. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 89
An alternate pathophysiologic paradigm of sepsis and septic shock
Kumar, A. (2013) · Virulence · doi:10.4161/viru.26913 · Cited by 90
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Fraser, M., Brown, Z., Houldsworth, M., Borman, A. M., & Johnson, E. M. (2015) · Medical Mycology · doi:10.1093/mmy/myv085 · Cited by 84
Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients
Eschenauer, G. A., Kwak, E. J., Humar, A., Potoski, B. A., Clarke, L. G., Shields, R. K., Abdel‐Massih, R., Silveira, F. P., Verhidis, P., Clancy, C. J., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12993 · Cited by 86
Paiva, J.-A., Pereira, J. M., Tabah, A., Mikstacki, A., de Carvalho, F. B., Koulenti, D., Ruckly, S., Çakar, N., Misset, B., Dimopoulos, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1229-1 · Cited by 91
Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.006 · Cited by 86
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 90
Current Options in Antifungal Pharmacotherapy
Mohr, J., Johnson, M. D., Cooper, T., Lewis, J. S., & Ostrosky-Zeichner, L. L. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.614 · Cited by 89
on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva), Giacobbe, D. R., Mikulska, M., Tumbarello, M., Furfaro, E., Spadaro, M., Losito, A. R., Mesini, A., PASCALE, G. D., Marchese, A. E., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1763-5 · Cited by 85
Perl, T., Jünger, M., Vautz, W., Nolte, J., Kuhns, M., Zepelin, M. B., & Quintel, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02037.x · Cited by 83
Lorente, L., Jiménez, A., Santana, M. C., Iribarren, J. L., Jiménez, J. J., Martin, M. M. I. D. O., & Mora, M. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000284589.63641.b8 · Cited by 83
Adherence to recommendations for the use of antifungal agents in a tertiary care hospital
Nivoix, Y., Launoy, A., Lutun, P., Moulin, J., Pang, K.-A. P., Fornecker, L., Wolf, M., Levêque, D., Letscher‐Bru, V., Beretz, L., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks256 · Cited by 83
Hermsen, E. D., Zapapas, M. K., Maiefski, M., Rupp, M. E., Freifeld, A. G., & Kalil, A. C. (2011) · Critical Care · doi:10.1186/cc10366 · Cited by 83
Pfaller, M. A., Huband, M. D., Flamm, R. K., Bien, P. A., & Castanheira, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-19 · Cited by 80
Breazzano, M. P., Bond, J. B., Bearelly, S., Kim, D. H., Donahue, S. P., Lum, F., & Olsen, T. W. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.07.015 · Cited by 82
Mylonakis, E. E., Zacharioudakis, I. M., Clancy, C. J., Nguyen, M. H., & Pappas, P. G. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01756-17 · Cited by 81
Candidaemia in internal medicine departments: the burden of a rising problem
Bassetti, M., Molinari, M. P., Mussap, M., Viscoli, C., & Righi, E. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12155 · Cited by 81
Davis, S. E., Hopke, A. R., Minkin, S. C., Montedonico, A. E., Wheeler, R. T., & Reynolds, T. B. (2014) · Infection and Immunity · doi:10.1128/iai.01612-14 · Cited by 82
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M., Williams, C., Munro, C. A., Jones, B., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 82
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Barton, R., Bijie, H., Bille, J., Chang, S.-C., da Luz Martins, M., Duse, A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.01.002 · Cited by 80
Hosting Infection: Experimental Models to AssayCandidaVirulence
MacCallum, D. M. (2011) · International Journal of Microbiology · doi:10.1155/2012/363764 · Cited by 86
Metadata
- Authors
- Morrell, M., Fraser, V. J., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Pulmonary and Critical Care Division
- Corresponding author
- Kollef, Marin H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-09
- Volume
- 49
- Issue
- 9
- Pages
- 3640-3645
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1195428
- OpenAlex
- W2137575148
- Cited by
- 1,286
- References
- 47
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 41 · 2023: 33 · 2022: 53 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 65 · 2017: 67 · 2016: 71 · 2015: 77 · 2014: 97 · 2013: 75 · 2012: 78
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- candidemia, fungemia, empirical antifungal therapy, treatment delay, blood culture, in-hospital mortality, APACHE II score, prior antibiotic use, rapid diagnostic tests
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candidiasis, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Logistic Models, Fungemia, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
